Skip to main content
PMC home page
Journal of the National Medical Association logoLink to Journal of the National Medical Association
letter
. 1982 Jul;74(7):675–682.

Tourette's Syndrome in a Black Woman with Associated Triple X and 9p Mosaicism

D N Singh, G L Howe, H W Jordan, S Hara
PMCID: PMC2552914  PMID: 6956751

Abstract

A review of the literature and a rare case of Tourette's syndrome in a black woman in association with triple X and 9p mosaicism are presented.

Full text

PDF
675

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abuzzahab F. E., Sr, Anderson F. O. Gilles de la Tourette's syndrome; international registry. Minn Med. 1973 Jun;56(6):492–496. [PubMed] [Google Scholar]
  2. Baker E. F. Gilles de la Tourette Syndrome Treated by Bimedial Frontal Leucotomy. Can Med Assoc J. 1962 Apr 21;86(16):746–747. [PMC free article] [PubMed] [Google Scholar]
  3. Barr M. L., Sergovich F. R., Carr D. H., Saver E. L. The triplo-X female: an appraisal based on a study of 12 cases and a review of the literature. Can Med Assoc J. 1969 Sep 6;101(5):247–258. [PMC free article] [PubMed] [Google Scholar]
  4. Browne T. R. Clonazepam. A review of a new anticonvulsant drug. Arch Neurol. 1976 May;33(5):326–332. doi: 10.1001/archneur.1976.00500050012003. [DOI] [PubMed] [Google Scholar]
  5. Caine E. D., Margolin D. I., Brown G. L., Ebert M. H. Gilles de la Tourette's syndrome, tardive dyskinesia, and psychosis in an adolescent. Am J Psychiatry. 1978 Feb;135(2):241–243. doi: 10.1176/ajp.135.2.241. [DOI] [PubMed] [Google Scholar]
  6. Challas G., Chapel J. L., Jenkins R. L. Tourette's disease: control of symptoms and its clinical course. Int J Neuropsychiatry. 1967 Aug;3(Suppl):95–109. [PubMed] [Google Scholar]
  7. Cohen D. J., Shaywitz B. A., Caparulo B., Young J. G., Bowers M. B., Jr Chronic, multiple tics of Gilles de la Tourette's disease. CSF acid monoamine metabolites after probenecid administration. Arch Gen Psychiatry. 1978 Feb;35(2):245–250. doi: 10.1001/archpsyc.1978.01770260123015. [DOI] [PubMed] [Google Scholar]
  8. Cohen D. J., Shaywitz B. A., Young J. G., Carbonari C. M., Nathanson J. A., Lieberman D., Bowers M. B., Jr, Maas J. W. Central biogenic amine metabolism in children with the syndrome of chronic multiple tics of Gilles de la Tourette: norepinephrine, serotonin, and dopamine. J Am Acad Child Psychiatry. 1979 Spring;18(2):320–341. doi: 10.1016/s0002-7138(09)61046-3. [DOI] [PubMed] [Google Scholar]
  9. Connell P. H., Corbett J. A., Horne D. J., Mathews A. M. Drug treatment of adolescent tiqueurs. A double-blind trial of Diazepam and Haloperidol. Br J Psychiatry. 1967 Apr;113(497):375–381. doi: 10.1192/bjp.113.497.375. [DOI] [PubMed] [Google Scholar]
  10. EISENBERG L., ASCHER E., KANNER L. A clinical study of Gilles de la Tourette's disease (maladie des tics) in children. Am J Psychiatry. 1959 Feb;115(8):715–723. doi: 10.1176/ajp.115.8.715. [DOI] [PubMed] [Google Scholar]
  11. Eldridge R., Sweet R., Lake R., Ziegler M., Shapiro A. K. Gilles de la Tourette's syndrome: clinical, genetic, psychologic, and biochemical aspects in 21 selected families. Neurology. 1977 Feb;27(2):115–124. doi: 10.1212/wnl.27.2.115. [DOI] [PubMed] [Google Scholar]
  12. Erenberg G., Rothner A. D. Tourette syndrome; a childhood disorder. Cleve Clin Q. 1978 Summer;45(2):207–212. doi: 10.3949/ccjm.45.2.207. [DOI] [PubMed] [Google Scholar]
  13. Feinberg M., Carroll B. J. Effects of dopamine agonists and antagonists in Tourette's disease. Arch Gen Psychiatry. 1979 Aug;36(9):979–985. doi: 10.1001/archpsyc.1979.01780090065007. [DOI] [PubMed] [Google Scholar]
  14. Fernando S. J. Gilles de la Tourette's syndrome. A report on four cases and a review of published case reports. Br J Psychiatry. 1967 Jun;113(499):607–617. doi: 10.1192/bjp.113.499.607. [DOI] [PubMed] [Google Scholar]
  15. Ford C. V., Gottlieb F. An objective evaluation of haloperidol in Gilles de la Tourette's syndrome. Dis Nerv Syst. 1969 May;30(5):328–332. [PubMed] [Google Scholar]
  16. Fras I. Gilles de la Tourette's syndrome. Effects of tricyclic antidepressants. N Y State J Med. 1978 Jul;78(8):1230–1232. [PubMed] [Google Scholar]
  17. Fras I., Karlavage J. The use of methylphenidate and imipramine in Gilles de la Tourette's disease in children. Am J Psychiatry. 1977 Feb;134(2):195–197. doi: 10.1176/ajp.134.2.195. [DOI] [PubMed] [Google Scholar]
  18. Friel P. B. Familial incidence of Gilles de la Tourette's disease, with observations on aetiology and treatment. Br J Psychiatry. 1973 Jun;122(571):655–658. doi: 10.1192/bjp.122.6.655. [DOI] [PubMed] [Google Scholar]
  19. Funderburk S. J., Sparkes R. S., Klisak I. The 9p-syndrome. J Med Genet. 1979 Feb;16(1):75–79. doi: 10.1136/jmg.16.1.75. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Goforth E. G. A single case study. Gilles de la Tourette's syndrome. J Nerv Ment Dis. 1974 Apr;158(4):306–309. doi: 10.1097/00005053-197404000-00008. [DOI] [PubMed] [Google Scholar]
  21. Golden G. S. Gilles de la Tourette's syndrome following methylphenidate administration. Dev Med Child Neurol. 1974 Feb;16(1):76–78. doi: 10.1111/j.1469-8749.1974.tb02715.x. [DOI] [PubMed] [Google Scholar]
  22. Golden G. S. The effect of central nervous system stimulants on Tourette syndrome. Ann Neurol. 1977 Jul;2(1):69–70. doi: 10.1002/ana.410020113. [DOI] [PubMed] [Google Scholar]
  23. Golden G. S. Tics and Tourette's: a continuum of symptoms? Ann Neurol. 1978 Aug;4(2):145–148. doi: 10.1002/ana.410040208. [DOI] [PubMed] [Google Scholar]
  24. Gonce M., Barbeau A. Seven cases of Gilles de la tourette's syndrome: partial relief with clonazepam: a pilot study. Can J Neurol Sci. 1977 Nov;4(4):279–283. doi: 10.1017/s0317167100025129. [DOI] [PubMed] [Google Scholar]
  25. Healy C. E. Gilles de la Tourette's syndrome (maladie des tics). Successful treatment with haloperidol. Am J Dis Child. 1970 Jul;120(1):62–63. doi: 10.1001/archpedi.1970.02100060096015. [DOI] [PubMed] [Google Scholar]
  26. Johannsson B., Roos B. E. 5-Hydroxyindoleacetic acid and homovanillic acid in cerebrospinal fluid of patients with neurological diseases. Eur Neurol. 1974;11(1):37–45. doi: 10.1159/000114304. [DOI] [PubMed] [Google Scholar]
  27. Johnson G. G., Pepple J. M., Singer H. S., Littlefield J. W. HGPRT in the Gilles de la Tourette syndrome. N Engl J Med. 1977 Aug 11;297(6):339–339. doi: 10.1056/NEJM197708112970620. [DOI] [PubMed] [Google Scholar]
  28. Klawans H. L., Falk D. K., Nausieda P. A., Weiner W. J. Gilles de la Tourette syndrome after long-term chlorpromazine therapy. Neurology. 1978 Oct;28(10):1064–1066. doi: 10.1212/wnl.28.10.1064. [DOI] [PubMed] [Google Scholar]
  29. Kondo K., Kabasawa T. Improvement in Gilles de la Tourette syndrome after corticosteroid therapy. Ann Neurol. 1978 Oct;4(4):387–387. doi: 10.1002/ana.410040423. [DOI] [PubMed] [Google Scholar]
  30. MAZUR W. P. Gilles de la tourette's syndrome. Edinb Med J. 1953 Oct;60(10):427–433. [PMC free article] [PubMed] [Google Scholar]
  31. Merril C. R., Leavitt J., Van Keuren M. L., Ebert M. H., Caine E. D. Hypoxanthine guanine phosphoribosyltransferase (HGPRT) in Gilles de la Tourette syndrome. Neurology. 1979 Jan;29(1):131–134. doi: 10.1212/wnl.29.1.131. [DOI] [PubMed] [Google Scholar]
  32. Merskey H. A case of multiple tics with vocalisation (partial syndrome of Gilles de la Tourette) and XYY karyotype. Br J Psychiatry. 1974 Dec;125:593–594. doi: 10.1192/bjp.125.6.593. [DOI] [PubMed] [Google Scholar]
  33. Messiha F. S., Knopp W., Vanecko S., O'Brien V., Corson S. A. Haloperidol therapy in Tourette's syndrome: neurophysiological, biochemical and behavioral correlates. Life Sci I. 1971 Apr 15;10(8):449–457. doi: 10.1016/0024-3205(71)90110-x. [DOI] [PubMed] [Google Scholar]
  34. Moldofsky H., Tullis C., Lamon R. Multiple tic syndrome (Giles de la Tourette's syndrome). J Nerv Ment Dis. 1974 Oct;159(4):282–292. doi: 10.1097/00005053-197410000-00007. [DOI] [PubMed] [Google Scholar]
  35. Moldofsky H., Tullis C., Lamon R. Multiple tic syndrome (Giles de la Tourette's syndrome). J Nerv Ment Dis. 1974 Oct;159(4):282–292. doi: 10.1097/00005053-197410000-00007. [DOI] [PubMed] [Google Scholar]
  36. Morphew J. A., Sim M. Gilles de la Tourette's syndrome: a clinical and psychopathological study. Br J Med Psychol. 1969 Dec;42(4):293–301. doi: 10.1111/j.2044-8341.1969.tb02083.x. [DOI] [PubMed] [Google Scholar]
  37. Murray T. J. Tourette's syndrome: a treatable tic. Can Med Assoc J. 1978 Jun 10;118(11):1407–1410. [PMC free article] [PubMed] [Google Scholar]
  38. Nee L. E., Caine E. D., Polinsky R. J., Eldridge R., Ebert M. H. Gilles de la Tourette syndrome: clinical and family study of 50 cases. Ann Neurol. 1980 Jan;7(1):41–49. doi: 10.1002/ana.410070109. [DOI] [PubMed] [Google Scholar]
  39. Pary R. J. The "psychotic" curse. Am J Psychiatry. 1979 May;136(5):715–716. doi: 10.1176/ajp.136.5.715. [DOI] [PubMed] [Google Scholar]
  40. Pollack M. A., Cohen N. L., Friedhoff A. J. Gilles de la Tourette's syndrome. Familial occurrence and precipitation by methylphenidate therapy. Arch Neurol. 1977 Oct;34(10):630–632. doi: 10.1001/archneur.1977.00500220064011. [DOI] [PubMed] [Google Scholar]
  41. Ross M. S., Moldofsky H. A comparison of pimozide and haloperidol in the treatment of Gilles de la Tourette's syndrome. Am J Psychiatry. 1978 May;135(5):585–587. doi: 10.1176/ajp.135.5.585. [DOI] [PubMed] [Google Scholar]
  42. SEIGNOT J. N. [A case of tic of Gilles de la Tourette cured by R 1625]. Ann Med Psychol (Paris) 1961 Mar;119(1):578–579. [PubMed] [Google Scholar]
  43. Saldaña-Garcia P. Dermatoglyphic findings in 54 triple-X females and a review of some general principles applying to the soles in sex chromosome aneuploidy. J Med Genet. 1975 Jun;12(2):185–192. doi: 10.1136/jmg.12.2.185. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Sanders D. G. Familial occurrence of Gilles de la Tourette syndrome. Report of the syndrome occurring in a father and son. Arch Gen Psychiatry. 1973 Mar;28(3):326–328. doi: 10.1001/archpsyc.1973.01750330028004. [DOI] [PubMed] [Google Scholar]
  45. Shapiro A. K. Gilles de la Tourette's disease. Am J Psychiatry. 1972 Jul;129(1):99–99. doi: 10.1176/ajp.129.1.99. [DOI] [PubMed] [Google Scholar]
  46. Shapiro A. K., Shapiro E. Gilles de la Tourette's syndrome. Am Fam Physician. 1974 Jun;9(6):94–96. [PubMed] [Google Scholar]
  47. Shapiro A. K., Shapiro E. Treatment of Gilles de la Tourette's Syndrome with haloperidol. Br J Psychiatry. 1968 Mar;114(508):345–350. doi: 10.1192/bjp.114.508.345. [DOI] [PubMed] [Google Scholar]
  48. Shapiro A. K., Shapiro E., Wayne H., Clarkin J. The psychopathology of Gilles de la Tourette's syndrome. Am J Psychiatry. 1972 Oct;129(4):427–434. doi: 10.1176/ajp.129.4.427. [DOI] [PubMed] [Google Scholar]
  49. Shapiro A. K., Shapiro E., Wayne H. Treatment of Tourette's syndrome with haloperidol, review of 34 cases. Arch Gen Psychiatry. 1973 Jan;28(1):92–97. doi: 10.1001/archpsyc.1973.01750310070010. [DOI] [PubMed] [Google Scholar]
  50. Singer H. S., Pepple J. M., Ramage A. L., Butler I. J. Gilles de la Tourette syndrome: further studies and thoughts. Ann Neurol. 1978 Jul;4(1):21–25. doi: 10.1002/ana.410040105. [DOI] [PubMed] [Google Scholar]
  51. Snyder S. H. Catecholamines in the brain as mediators of amphetamine psychosis. Arch Gen Psychiatry. 1972 Aug;27(2):169–179. doi: 10.1001/archpsyc.1972.01750260021004. [DOI] [PubMed] [Google Scholar]
  52. Snyder S. H., Taylor K. M., Coyle J. T., Meyerhoff J. L. The role of brain dopamine in behavioral regulation and the actions of psychotropic drugs. Am J Psychiatry. 1970 Aug;127(2):199–207. doi: 10.1176/ajp.127.2.199. [DOI] [PubMed] [Google Scholar]
  53. Stevens J. R., Blachly P. H. Successful treatment of the maladie des tics. Gilles de la Tourette's syndrome. Am J Dis Child. 1966 Dec;112(6):541–545. doi: 10.1001/archpedi.1966.02090150085006. [DOI] [PubMed] [Google Scholar]
  54. Sweet R. D., Solomon G. E., Wayne H., Shapiro E., Shapiro A. K. Neurological features of Gilles de la Tourette's syndrome. J Neurol Neurosurg Psychiatry. 1973 Feb;36(1):1–9. doi: 10.1136/jnnp.36.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. TOBIN W. G., REINHART J. B. Tic de Glles de la Tourette. Am J Dis Child. 1961 Jun;101:778–783. doi: 10.1001/archpedi.1961.04020070092013. [DOI] [PubMed] [Google Scholar]
  56. Ulus I. H., Wurtman R. J. Choline administration: activation of tyrosine hydroxylase in dopaminergic neurons of rat brain. Science. 1976 Dec 3;194(4269):1060–1061. doi: 10.1126/science.10629. [DOI] [PubMed] [Google Scholar]
  57. Van Woert M. H., Jutkowitz R., Rosenbaum D., Bowers M. B., Jr Gilles de la Tourette's syndrome: biochemical approaches. Res Publ Assoc Res Nerv Ment Dis. 1976;55:459–465. [PubMed] [Google Scholar]
  58. Van Woert M. H., Rosenbaum D., Howieson J., Bowers M. B., Jr Long-term therapy of myoclonus and other neurologic disorders with L-5-hydroxytryptophan and carbidopa. N Engl J Med. 1977 Jan 13;296(2):70–75. doi: 10.1056/NEJM197701132960203. [DOI] [PubMed] [Google Scholar]
  59. Waldo M. C., Cohen D. J., Caparulo B. K., Young J. G., Prichard J. W., Shaywitz B. A. EEG profiles of neuropsychiatrically disturbed children. J Am Acad Child Psychiatry. 1978 Autumn;17(4):656–670. doi: 10.1016/s0002-7138(09)61018-9. [DOI] [PubMed] [Google Scholar]
  60. Wassman E. R., Eldridge R., Abuzzahab S., Sr, Nee L. Gilles de la Tourette syndrome: clinical and genetic studies in a midwestern city. Neurology. 1978 Mar;28(3):304–307. doi: 10.1212/wnl.28.3.304. [DOI] [PubMed] [Google Scholar]
  61. Woodrow K. M. Gilles de la Tourette's disease--a review. Am J Psychiatry. 1974 Sep;131(9):1000–1003. doi: 10.1176/ajp.131.9.1000. [DOI] [PubMed] [Google Scholar]
  62. Yaryura-Tobias J. A. Gilles de la Tourette syndrome. Interactions with other neuropsychiatric disorders. Acta Psychiatr Scand. 1979 Jan;59(1):9–16. doi: 10.1111/j.1600-0447.1979.tb06941.x. [DOI] [PubMed] [Google Scholar]

Articles from Journal of the National Medical Association are provided here courtesy of National Medical Association

RESOURCES